TJ

The Journal of Prevention of Alzheimer s Disease

The Journal of Prevention of Alzheimer’s Disease (JPAD) is an e-only Gold Open Access journal that publishes reviews, original research articles and short reports to improve knowledge in Alzheimer's disease prevention, including neurosciences, biomarkers, imaging, epidemiology, public health, physical cognitive exercise, nutrition, risk and protective factors, drug development, trial design, and health economics outcomes. It also publishes meeting abstracts from the Clinical Trial on Alzheimer's Disease (CTAD) Conference and is indexed in MEDLINE, SCIE (WoS), and Scopus.

Looking to publish in The Journal of Prevention of Alzheimer s Disease? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Clinical Neurology
Impact Factor 7.8
Quartile Q1
Open Access Type Open
ISSN 2274-5807
eISSN 2426-0266
Invitation Only No
Cost Range Article Publishing Charge: USD 4060 excluding taxes for all articles.

Submission Instructions

The Journal of Prevention of Alzheimer s Disease accepts the following article types. Click on an article type to view submission instructions.

Original Papers

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must not exceed 250 words. Abstract must be structured.
Manuscript Manuscript must be limited to a maximum of 5,500 text words. Articles must be divided into clearly defined and numbered sections. The manuscript must include 1 to 6 keywords in English and, if generative AI was used in manuscript preparation, a declaration section immediately before the references specifying the tool used and the reason for using it.
References References must be limited to 60. AMA Manual of Style, 11th edition, is required. References must be cited by number in square brackets in the text and listed in numerical order of appearance, with the first 6 authors given followed by 'et al.' for works with more than 6 authors.
Figures & Tables A maximum of 5 graphics, including tables, figures, or appendices, is allowed. Figures and other graphical media must be supplied as separate files along with the manuscript. Tables must be submitted as editable text rather than images and must include captions.
Reformat to The Journal of Prevention of Alzheimer s Disease using Livewrite Premium

Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract A narrative abstract is required. Abstract must not exceed 250 words. Abstract must be narrative.
Manuscript Manuscript must be limited to 6,500 text words. Articles must be divided into clearly defined and numbered sections, with the abstract excluded from section numbering. Manuscripts must include 1 to 6 keywords in English and, if generative AI or AI-assisted technologies were used in writing, a declaration statement immediately above the references identifying the tool and reason for use.
References References must be limited to 120. AMA Manual of Style, 11th edition, is required. References must be cited by number in square brackets, listed in reference-list order of appearance, and for more than 6 authors must show the first 6 followed by 'et al.'.
Figures & Tables Reviews must be limited to 5 graphics, including tables, figures, or appendices. Figures and other graphical media must be uploaded as separate files, and tables must be submitted as editable text. Tables must be numbered consecutively, cited in the text, and include captions, and all figures must be cited in the text and include captions.
Reformat to The Journal of Prevention of Alzheimer s Disease using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. The abstract must be no more than 150 words. The abstract must be unstructured.
Manuscript The manuscript must be limited to 3,500 text words. Articles must be divided into clearly defined and numbered sections. The manuscript must include 1 to 6 keywords in English and, if AI tools were used in writing, a declaration section immediately before the references specifying the tool used and the reason for using it.
References The reference list must be limited to 30 references. References must be cited in the text using numbers in square brackets and listed in the reference list in the order they appear, listing the first 6 authors followed by 'et al.' when there are more than 6 authors.
Figures & Tables The submission must be limited to 2 graphics, including tables, figures, or appendices. Figures and other graphical media must be supplied as separate files along with the manuscript. Tables must be submitted as editable text rather than images and each figure or table must be cited in the manuscript text with a caption.
Reformat to The Journal of Prevention of Alzheimer s Disease using Livewrite Premium

Letters To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is not required for Letters To The Editor.
Manuscript Letters To The Editor must be limited to 800 text words. Articles must be divided into clearly defined and numbered sections. A declaration of generative AI and AI-assisted technologies in the writing process must be included immediately before the references if AI tools were used, and 1 to 6 keywords in English must be provided.
References Letters To The Editor must be limited to 5 references. Submissions must adhere to the AMA Manual of Style, 11th edition. References must be cited by number in square brackets in the text and listed in the reference list in the order of first appearance, with the first 6 authors listed followed by 'et al.' when there are more than 6 authors.
Figures & Tables Letters To The Editor must be limited to 1 graphic, including tables, figures, or appendices. Figures and other graphical media must be supplied as separate files along with the manuscript. Tables must be submitted as editable text rather than images and all figures and tables must be cited in the manuscript text and include captions.
Reformat to The Journal of Prevention of Alzheimer s Disease using Livewrite Premium

Recent Publications

Relative importance of blood-based biomarkers for Alzheimer’s disease-specific neurodegeneration and cognitive decline

Keun You Kim, Hyunsun Ham, Eun Jin Yoon, Eosu Kim, Yu Kyeong Kim, Jun-Young Lee

10.1016/j.tjpad.2026.100644
View Publication

Can we identify people with Alzheimer’s disease from examination of the eye? A bidirectional Mendelian randomization (MR) study

Humayun Kiser, Ashley Budu-Aggrey, Jessica N. Cooke Bailey, Ana Villaplana-Velasco, Miguel O. Bernabeu, Xiaofan Jiang, Christopher G. Owen, Jonathan L. Haines, Louis R. Pasquale, Stuart MacGregor, Xiaoyi Raymond Gao, Janey L. Wiggs, Chen Jiang, Hélène Choquet, George Davey Smith, Patrick G. Kehoe, Neil M. Davies, Aimee L. Hanson, Emma L. Anderson, Denize Atan

10.1016/j.tjpad.2026.100635
View Publication

MIND GamePack: A novel digital health technology for assessment of participants with and without cognitive impairment

Jake A. Galler, Liuqing Yang, Chao-Yi Wu, Cathrine Young, Edmarie Guzmán-Vélez, Katherine W. Cropp, Anthony W. Bannon, Hiroko H. Dodge, Jessica A. Gerber, Steven E. Arnold

10.1016/j.tjpad.2026.100642
View Publication

Sex differences in subjective cognition among middle-aged and older Hispanic/Latino adults: Findings from the HCHS/SOL and SOL-INCA

Ariana M. Stickel, Wassim Tarraf, Sayaka Kuwayama, Ammie Xie, Rachel Membreno, Carolina L. Costa, Carlos E.E. Araujo Menendez, Zvinka Z. Zlatar, Krista M. Perreira, Haibo Zhou, Martha Daviglus, Amber Pirzada, Paola Filigrana, Bonnie E. Levin, Linda C. Gallo, Hector M. González, Sarah J. Banks

10.1016/j.tjpad.2026.100637
View Publication

Suboptimal adherence to brain health recommendations in patients pursuing anti-amyloid antibody therapy for Alzheimer’s disease: Report from the Brain Health Vital Signs project

Kirk R Daffner, Kayla Riera, George R Ghorayeb, Brittany M McFeeley, Emma Weizenbaum, Kim Willment, Seth A Gale

10.1016/j.tjpad.2026.100640
View Publication

Frequently asked questions

How long does it take to publish?

6 days submission to first decision; 31 days submission to decision after review; 64 days submission to acceptance.

Reformat to The Journal of Prevention of Alzheimer s Disease using Livewrite Premium

Is a cover letter required?

A cover/response letter is required when submitting a revised manuscript, with a point-by-point response to reviewers’ comments.

Reformat to The Journal of Prevention of Alzheimer s Disease using Livewrite Premium

What are the publication costs?

Article Publishing Charge: USD 4060 excluding taxes for all articles.

Reformat to The Journal of Prevention of Alzheimer s Disease using Livewrite Premium

Research Topics

Dementia and Cognitive Impairment Research Alzheimer's disease research and treatments Nutritional Studies and Diet Health Systems, Economic Evaluations, Quality of Life Cancer-related cognitive impairment studies Frailty in Older Adults Neurological Disease Mechanisms and Treatments Health, Environment, Cognitive Aging Diet and metabolism studies Ethics in Clinical Research Cholinesterase and Neurodegenerative Diseases Functional Brain Connectivity Studies Traumatic Brain Injury Research Intracerebral and Subarachnoid Hemorrhage Research Computational Drug Discovery Methods Intensive Care Unit Cognitive Disorders Neurological Disorders and Treatments Older Adults Driving Studies Schizophrenia research and treatment Nutrition and Health in Aging Health disparities and outcomes Neuroinflammation and Neurodegeneration Mechanisms Machine Learning in Healthcare Tryptophan and brain disorders Bioinformatics and Genomic Networks

Related Journals

CD
Current Diabetes Reports Springer Science+Business Media
CO
Current Opinion in Neurology LIPPINCOTT WILLIAMS & WILKINS
NR
Neurochemical Research Springer Science+Business Media
In
Inflammation Springer Science+Business Media
EP
EJNMMI Physics Springer Science+Business Media
CH
Current Hematologic Malignancy Reports Springer Science+Business Media